ARTICLE | Financial News
Alta closes $130M fund for biotechs, tech-based healthcare services
June 12, 2018 9:13 PM UTC
Alta Partners closed its Alta Partners NextGen Fund I at $130 million to invest in biotech and healthcare delivery companies. Alta told BioCentury the fund will invest in about six to eight companies.
Alta has made undisclosed investments in four companies through the fund: antibody company Allakos Inc. (San Carlos, Calif.); xenotransplantation company eGenesis Inc. (Cambridge, Mass.); infectious disease company Vir Biotechnology Inc. (San Francisco, Calif.); and mobile and virtual healthcare company DispatchHealth Holdings Inc. (Denver, Colo.)...